Skip to main content
. Author manuscript; available in PMC: 2019 Jul 16.
Published in final edited form as: Pharmacogenomics J. 2009 Dec 29;10(3):191–199. doi: 10.1038/tpj.2009.57

Table 1.

Genes included in the DMET 1.0 panel

P450 Enzymes Non-P450 enzymes Transporters Other
CYP1A1 CYP4F2 ADH1A CROT NQO1 ABCB1 SLC15A2 AHR
CYP1A2 CYP4F3 ADH1B DYPD SULT1A1 ABCB4 SLC16A1 NR1I2
CYP1B1 CYP4F8 ADH4 EPHX1 SULT1A2 ABCB7 SLC19A1 NR3C1
CYP2A13 CYP4Z1 ADH5 FMO1 SULT1A3 ABCB11 SLC22A1 PPARD
CYP2A6 CYP46A1 ADH6 FMO2 SULT1B1 ABCC1 SLC22A2 PPARG
CYP2A7 CYPA1 ADH7 FMO3 SULT1C1 ABCC2 SLC22A3 RALBP1
CYP2B6 CYP51A1 ALDH1A1 FMO4 SULT1C2 ABCC3 SLC22A4 RPL13
CYP2B7P1 CYP7A1 ALDH2 FMO5 SULT1E1 ABCC4 SLC22A5 SPG7
CYP2C9 CYP7B1 ALDH3A1 FMO6 SULT2A1 ABCC5 SLC22A6 XDH
CYP2C8 CYP8A1 AOX1 GSTA1 SULT2B1 ABCC6 SLC22A8
CYP2C19 CYP8B1 COA GSTA2 SULT4A1 ABCG2 SLC28A1
CYP2C18 CYP11A1 CHST1 GSTA3 TPMT ATP7A SLC28A2
CYP2D6 CYP11B1 CHST2 GSTA4 UGT1A1 ATP7B SLC28A3
CYP2E1 CYP11B2 CHST3 GSTA5 UGT1A3 SLC5A6 SLC29A1
CYP2F1 CYP17A1 CHST4 GSTM2 UGT1A4 SLC7A5 SLC29A2
CYP2J2 CYP19A1 CHST5 GSTM3 UGT1A6 SLC7A7 SLCO1A2
CYP281 CYP20A1 CHST6 GSTM4 UGT1A7 SLC10A1 SLCO1B1
CYP3A4 CYP21A2 CHST7 GSTO1 UGT1A8 SLC10A2 SLC1B3
CYP3A43 CYP24A1 CHST8 GSTP1 UGT2A1 SLC13A1 SLCO2B1
CYP3A5 CYP26A1 CHST9 HNMT UGT2B11 SLC15A1
CYP3A7 CYP26C1 CHST10 MAOB UGT2B15
CYP4A11 CYP27A1 CHST11 NAT1 UGT2B28
CYP4B1 CYP27B1 CHST13 NAT2 UGT2B4
CYP4F11 CYP39A1 COMT NNMT UGT8
CYP4F12 POR

Abbreviations: DMET, drug-metabolizing enzymes and transporters; SNP, single-nucleotide polymorphism.

The DMET assay and panel genotype samples for variations in 170 drug disposition genes, including 50 CYP450 genes, 72 non-CYP genes, 39 transporters and 9 other proteins involved in drug disposition. Assay genotyping identifies homozygote wild-type, homozygote variant or heterozygote alleles in 1256 SNPs and other genetic variation sites in these genes.